New Zealand markets closed

Talis Biomedical Corporation (TLIS)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
8.88+0.12 (+1.43%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close8.75
Open8.88
Bid8.16 x 3000
Ask8.50 x 1300
Day's range8.88 - 9.00
52-week range4.35 - 9.32
Volume3,246
Avg. volume8,649
Market cap16.163M
Beta (5Y monthly)1.71
PE ratio (TTM)N/A
EPS (TTM)-42.42
Earnings date28 Mar 2024 - 30 Mar 2024
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • GlobeNewswire

    Talis Biomedical Announces Exploration of Strategic Alternatives and Cost Reduction Plan to Preserve Cash

    REDWOOD CITY, Calif., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced it has initiated a process to explore strategic alternatives with the goal of maximizing shareholder value. While the Company has made progress developing the Talis One® system, it believes that this is a pr

  • GlobeNewswire

    Talis Biomedical Announces Second Quarter 2023 Financial Results and Business Update

    Conference call and webcast today at 4:30pm Eastern/1:30pm PacificREDWOOD CITY, Calif., Aug. 10, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today reported financial results for the second quarter ended June 30, 2023, and provided a business update. Recent Business Highlights Initiated clinical st

  • GlobeNewswire

    Talis Biomedical to Report Second Quarter 2023 Financial Results and Provide a Business Update on August 10, 2023

    REDWOOD CITY, Calif., Aug. 03, 2023 (GLOBE NEWSWIRE) -- Talis Biomedical Corporation (Nasdaq: TLIS), a diagnostic company dedicated to advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care, today announced that it will report second quarter 2023 financial results and provide a business update on Thursday, August 10, 2023, after market close. Company management will host a corresponding conference call beginnin